Cargando…
Ephrin-B2 inhibits cell proliferation and motility in vitro and predicts longer metastasis-free survival in breast cancer
The tyrosine kinase receptor EphB4 and its ligand ephrin-B2 interact through cell-to-cell contacts. Upon interaction, EphB4 transmits bidirectional signals. A forward signal inside EphB4-expressing cells is believed to suppress tumor growth, while inside the ephrin-expressing cells, an oncogenic rev...
Autores principales: | Magic, Zeljana, Sandström, Josefine, Perez-Tenorio, Gizeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831205/ https://www.ncbi.nlm.nih.gov/pubmed/31638179 http://dx.doi.org/10.3892/ijo.2019.4892 |
Ejemplares similares
-
EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancer
por: Husa, Anna-Maria, et al.
Publicado: (2016) -
Attenuation of Eph Receptor Kinase Activation in Cancer Cells by Coexpressed Ephrin Ligands
por: Falivelli, Giulia, et al.
Publicado: (2013) -
IP6K2 predicts favorable clinical outcome of primary breast cancer
por: Sandström, Josefine, et al.
Publicado: (2021) -
Host deficiency in ephrin-A1 inhibits breast cancer metastasis
por: Shiuan, Eileen, et al.
Publicado: (2020) -
Involvement of ephrin receptor A4 in pancreatic cancer cell motility and invasion
por: LIU, CHENGLI, et al.
Publicado: (2014)